isoleucine has been researched along with Infarction, Middle Cerebral Artery in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becktel, DA; Calderon, KE; Crumpacker, RH; Doyle, KP; Frye, JB; Garcia, FG; Gonzalez, S; Longo, FM; Morrison, HW; Nguyen, TV; Schnellmann, RG; Tavera-Garcia, MA; Yang, T; Zbesko, JC | 1 |
| Che, F; Chen, S; Cheng, J; Cui, Y; Gao, J; Hu, W; Kong, X; Li, H; Ren, J; Sun, J; Wan, Q; Xu, X; Yao, X | 1 |
2 other study(ies) available for isoleucine and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Post-Stroke Administration of the p75 Neurotrophin Receptor Modulator, LM11A-31, Attenuates Chronic Changes in Brain Metabolism, Increases Neurotransmitter Levels, and Improves Recovery.
Topics: Animals; Brain; Glutathione; Glycolysis; Infarction, Middle Cerebral Artery; Isoleucine; Mice; Mice, Inbred C57BL; Morpholines; Neuroprotective Agents; Neurotransmitter Agents; Receptor, Nerve Growth Factor | 2022 |
Transcranial direct-current stimulation confers neuroprotection by regulating isoleucine-dependent signalling after rat cerebral ischemia-reperfusion injury.
Topics: Animals; Brain Ischemia; Infarction, Middle Cerebral Artery; Isoleucine; Neuroprotection; Neuroprotective Agents; Oxygen; Rats; Reperfusion Injury; Signal Transduction; Transcranial Direct Current Stimulation | 2023 |